Recent News

Immunotherapy Might Not Be a Good Option for Mesothelioma

June 20, 2025

Mesothelioma is a rare and aggressive cancer mainly caused by asbestos exposure that creates challenges for patients and caregivers. Immune checkpoint inhibitors have brought hope to patients, but new data…

Multimodal Therapy to Treat Pleural Mesothelioma

June 13, 2025

Malignant pleural mesothelioma is a deadly cancer that is mainly caused by asbestos exposure. It affects the lungs’ lining. It is a very hard to treat cancer because it is…

Prospective Data Collection Initiative on Thoracic Malignancies (DuTOC)

June 6, 2025

Primary Outcome Measures Progression free survival Secondary outcome Measures Disease free survival Overall survival Health related quality of life Inclusion Criteria Age ≥ 18 years; Histo/cytopathological proof of a thoracic…

Gene Expression’s Relationship with Pleural Mesothelioma

June 6, 2025

Alterations in DNA of patients exposed to asbestos can lead to gene expression, which explains the development of malignant pleural mesothelioma, a rare and aggressive cancer. Scientists were able to…

CRS and HIPEC for Peritoneal Mesothelioma

May 30, 2025

Peritoneal mesothelioma is a rare and aggressive cancer linked to asbestos exposure. A promising option for treating the cancer includes cytoreductive surgery (CRS) with heated chemotherapy (HIPEC). A new article…

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma (INFINITE)

May 23, 2025

Primary Outcome Measures Overall Survival Secondary Outcome Measures Progression Free Survival Best Response: Objective Response Rate (ORR) Best Response: Disease Control Rate (DCR) Best Response: Clinical Benefit Rate (CBR) Other…

Analysis of 70 Mesothelioma Cases

May 23, 2025

Malignant pleural mesothelioma is a severe cancer mainly caused by asbestos exposure. It often appears decades after exposure. Early on, symptoms can be unclear, making it difficult to diagnose. Even…

PORT-7 for the Treatment of Mesothelioma

May 16, 2025

Results from a clinical trial being performed on malignant pleural mesothelioma patients will be presented at the American Association for Cancer Research meeting being held in Chicago, Illinois. Results will…

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis. (FLAT)

May 9, 2025

Primary Outcome Measures Time to Diagnosis Hospitalization time Secondary Outcome Measures Patient’s discomfort/pain Complications Rate of Non Specific Pleuritis Inclusion Criteria Undiagnosed pleural effusion with the character of a lymphocytic…

Ageing and Mesothelioma

May 9, 2025

Mesothelioma, a rare and aggressive cancer mainly caused by asbestos exposure, mostly affects the lining of the lungs, but can also affect the lining of the abdomen, heart, and testicles.…